1 Bansback N, "Using the health assessment questionnaire to estimate preferencebased single indices in patients with rheumatoid arthritis" 57 : 963-971, 2007
2 Bergner M, "The sickness impact Profile: development and final revision of a health status measure" 19 : 787-805, 1981
3 Fries JF, "The dimensions of health outcomes: the Health Assessment Questionnaire, disability and pain scales" 9 : 789-793, 1982
4 Ware JE, "SF-36 Health Survey Manual and Interpretation Guide"
5 Bae SC, "Psychometric evaluation of a Korean Health Assessment Questionnaire for clinical research" 25 : 1975-1979, 1998
6 Torrance GW, "Multiattribute utility function for a comprehensive health status classification system: Health Utilities Index Mark2" 34 : 702-722, 1996
7 Tanno M, "Modelling and cost-effectiveness analysis of etanercept in adults with rheumatoid arthritis in Japan: a preliminary analysis" 16 : 77-84, 2006
8 Brenna A, "Modeling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK" 43 : 62-72, 2004
9 Hurst NP, "Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D)" 36 : 551-559, 1997
10 Meenan RF, "Measuring health status in arthritis. The arthritis impact measurement scales" 23 : 146-152, 1980
1 Bansback N, "Using the health assessment questionnaire to estimate preferencebased single indices in patients with rheumatoid arthritis" 57 : 963-971, 2007
2 Bergner M, "The sickness impact Profile: development and final revision of a health status measure" 19 : 787-805, 1981
3 Fries JF, "The dimensions of health outcomes: the Health Assessment Questionnaire, disability and pain scales" 9 : 789-793, 1982
4 Ware JE, "SF-36 Health Survey Manual and Interpretation Guide"
5 Bae SC, "Psychometric evaluation of a Korean Health Assessment Questionnaire for clinical research" 25 : 1975-1979, 1998
6 Torrance GW, "Multiattribute utility function for a comprehensive health status classification system: Health Utilities Index Mark2" 34 : 702-722, 1996
7 Tanno M, "Modelling and cost-effectiveness analysis of etanercept in adults with rheumatoid arthritis in Japan: a preliminary analysis" 16 : 77-84, 2006
8 Brenna A, "Modeling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK" 43 : 62-72, 2004
9 Hurst NP, "Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D)" 36 : 551-559, 1997
10 Meenan RF, "Measuring health status in arthritis. The arthritis impact measurement scales" 23 : 146-152, 1980
11 Fries JF, "Measurement of patient outcome in arthritis" 23 : 137-145, 1980
12 Scott DL, "Limited correlation between the Health Assessment Questionnaire (HAQ) and EuroQol in rheumatoid arthritis: questionable validity of deriving quality adjusted life years from HAQ" 66 : 1534-1537, 2007
13 Linde L, "Health-related quality of life: validity, reliability, and responsiveness of SF-36, EQ-15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis" 35 : 1528-1537, 2008
14 Kim CG, "Health-related quality of life in korean patients with rheumatoid arthritis" 9 : S60-S72, 2002
15 Harrison MJ, "Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis" 8 : 21-, 2010
16 Sherrer YS, "Disability in rheumatoid arthritis: comparison of prognostic factors across three populations" 14 : 705-709, 1987
17 Kim MH, "Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases" 14 : 1401-1406, 2005
18 Torrance GW, "A utility maximization model for evaluation of health care programs" 7 : 118-133, 1972
19 Kaplan RM, "A general health policy model: update and applications" 23 : 203-235, 1988